• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

6,152
2,053
1,973
1,626
1,448

COUNTRY

1,008
795
248
216
175

CATEGORIES

  • 943
  • 189
  • 125
  • 327
    • 55
  • 471
  • 233
  • 264
  • 65
  • 78
  • 814
  • 1,445
  • 855
  • 24
  • 460
  • 1,370
  • 2,267
    • 89
    • 129
    • 71
    • 72
    • 43
    • 43
    • 21
    • 16
    • 20
    • 22
  • 25
  • 273
  • 49

PRICE

5,279
10,589
20,014
26,176

PUBLISHED

3,668
5,184
10,195
26,176

PRODUCT TYPE

22,067
1,956
1,009
892
164
37
21
19
6
4
1

Pharmaceuticals

The pharmaceutical industry has been for decades one of the most profitable worldwide. Serious challenges, such as the expiry of long-term lucrative patents (Lipitor, to mention just one) and the cuts in healthcare and R&D in many countries worldwide, can pose a challenge to the growth of the industry. Which drug can save the life of the pharmaceutical industry? Highly differentiated strategies: this is what companies should focus on now if they want to stay competitive. Do you want to know more?

You can get a detailed picture of the market and refine your marketing, brand, and sales strategies with the reliable, up-to-date business information provided by the extensive range of reports, books and subscriptions listed under Research and Markets’ Pharmaceuticals category. They cover markets, companies (big Pharma, mid-sized specialty pharmaceutical companies, generic manufacturers, and small firms), technologies, e-healthcare, pharmaeconomics, drug discovery, and drug delivery.

The product coverage is huge. It includes OTC drugs as well disorder and goal-specific products related to respiration, oncology, vitamins, cardio, analgesics, central nervous system, generics, immune disorders, and women’s health. Show Less
Read more

PRODUCT TITLE
Global and Chinese Diabetes Drugs Industry Report 2014 Global and Chinese Diabetes Drugs Industry Report 2014 - Product Thumbnail Image

Global and Chinese Diabetes Drugs Industry Report 2014

The Global and Chinese Diabetes Drugs Industry Report 2014 is a professional and in-depth study on the current state of the global diabetes drugs industry with a focus on the Chinese situation. The...

August 2014
FROM
Oncology Deals and Alliances of 2013 Oncology Deals and Alliances of 2013 - Product Thumbnail Image

Oncology Deals and Alliances of 2013

The Oncology Deals and Alliances of 2013 report provides comprehensive understanding and unprecedented access to the partnering deals and agreements entered into by the worlds leading healthcare companies...

August 2014
FROM
Cancer Monoclonal Antibody Partnering Terms and Agreements Cancer Monoclonal Antibody Partnering Terms and Agreements - Product Thumbnail Image

Cancer Monoclonal Antibody Partnering Terms and Agreements

The Cancer Monoclonal Antibody Partnering Agreements report provides an understanding and access to the cancer monoclonal antibody partnering deals and agreements entered into by the worlds leading...

August 2014
FROM

Knowledge Management in the Pharmaceutical Industry

The Pharmaceutical Industry has been undergoing a major transformation since the heady days of 'big pharma' in the 1970s and 80s. Patent expiry, the rise of generics, and the decline of the blockbuster...

August 2014
Licensing Terms and Agreements in Pharma, Biotech and Diagnostics Licensing Terms and Agreements in Pharma, Biotech and Diagnostics - Product Thumbnail Image Special Offer Sale Banner

Licensing Terms and Agreements in Pharma, Biotech and Diagnostics

The Licensing Terms and Agreements in Pharma, Biotech and Diagnostics report provides comprehensive understanding and unprecedented access to the licensing deals and agreements entered into by the worlds...

August 2014
FROM
Dental Partnering Terms and Agreements Dental Partnering Terms and Agreements - Product Thumbnail Image

Dental Partnering Terms and Agreements

The Dental Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the dental partnering deals and agreements entered into by the worlds leading healthcare...

August 2014
FROM
Competitor Analysis: GLP-1 Receptor Agonists Competitor Analysis: GLP-1 Receptor Agonists - Product Thumbnail Image

Competitor Analysis: GLP-1 Receptor Agonists

The Competitive Intelligence Report Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists as of August 2014 provides a competitor analysis in the development pipeline of novel GLP-1 analogs and GLP-1 receptor...

August 2014
FROM
Animal Health Deals and Alliances of 2013 Animal Health Deals and Alliances of 2013 - Product Thumbnail Image

Animal Health Deals and Alliances of 2013

The Animal Health Deals and Alliances of 2013 report provides comprehensive understanding and unprecedented access to the partnering deals and agreements entered into by the worlds leading healthcare...

August 2014
FROM
Discovery Stage Deals and Alliances of 2013 Discovery Stage Deals and Alliances of 2013 - Product Thumbnail Image

Discovery Stage Deals and Alliances of 2013

The Discovery Stage Deals and Alliances of 2013 report provides comprehensive understanding and unprecedented access to the partnering deals and agreements entered into by the worlds leading healthcare...

August 2014
FROM

Willful Ignorance. The Mismeasure of Uncertainty

An original account of willful ignorance and how this principle relates to modern probability and statistical methods Through a series of colorful stories about great thinkers and the problems they...

August 2014

Idiopathic (Essential) Hypertension - Pipeline Review, H2 2014

Idiopathic (Essential) Hypertension - Pipeline Review, H2 2014 Summary This, ‘Idiopathic (Essential) Hypertension - Pipeline Review, H2 2014’, provides an overview of the Idiopathic (Essential) Hypertension’s...

July 2014
FROM

Essential Thrombocythemia - Pipeline Review, H2 2014

Essential Thrombocythemia - Pipeline Review, H2 2014 Summary This, ‘Essential Thrombocythemia - Pipeline Review, H2 2014’, provides an overview of the Essential Thrombocythemia’s therapeutic pipeline. This...

July 2014
FROM

Arteriosclerosis - Pipeline Review, H2 2014

Arteriosclerosis - Pipeline Review, H2 2014 Summary This, ‘Arteriosclerosis - Pipeline Review, H2 2014’, provides an overview of the Arteriosclerosis’s therapeutic pipeline. This report provides...

July 2014
FROM

Rotavirus Infections - Pipeline Review, H2 2014

Rotavirus Infections - Pipeline Review, H2 2014 Summary This, ‘Rotavirus Infections - Pipeline Review, H2 2014’, provides an overview of the Rotavirus Infections’s therapeutic pipeline. This report...

July 2014
FROM

T-Cell Leukemia - Pipeline Review, H2 2014

T-Cell Leukemia - Pipeline Review, H2 2014 Summary This, ‘T-Cell Leukemia - Pipeline Review, H2 2014’, provides an overview of the T-Cell Leukemia’s therapeutic pipeline. This report provides comprehensive...

July 2014
FROM

Botulism - Pipeline Review, H2 2014

Botulism - Pipeline Review, H2 2014 Summary This, ‘Botulism - Pipeline Review, H2 2014’, provides an overview of the Botulism’s therapeutic pipeline. This report provides comprehensive information...

July 2014
FROM

Uterine Leiomyoma (Uterine Fibroids) - Pipeline Review, H2 2014

Uterine Leiomyoma (Uterine Fibroids) - Pipeline Review, H2 2014 Summary This, ‘Uterine Leiomyoma (Uterine Fibroids) - Pipeline Review, H2 2014’, provides an overview of the Uterine Leiomyoma (Uterine...

July 2014
FROM

Febrile Neutropenia - Pipeline Review, H2 2014

Febrile Neutropenia - Pipeline Review, H2 2014 Summary This, ‘Febrile Neutropenia - Pipeline Review, H2 2014’, provides an overview of the Febrile Neutropenia’s therapeutic pipeline. This report...

July 2014
FROM

Neuro Endocrine (Carcinoid) Carcinoma - Pipeline Review, H2 2014

Neuro Endocrine (Carcinoid) Carcinoma - Pipeline Review, H2 2014 Summary This, ‘Neuro Endocrine (Carcinoid) Carcinoma - Pipeline Review, H2 2014’, provides an overview of the Neuro Endocrine (Carcinoid)...

July 2014
FROM

Down Syndrome - Pipeline Review, H2 2014

Down Syndrome - Pipeline Review, H2 2014 Summary This, ‘Down Syndrome - Pipeline Review, H2 2014’, provides an overview of the Down Syndrome’s therapeutic pipeline. This report provides comprehensive...

July 2014
FROM
Loading Indicator

Our Clients

Our clients' logos